Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Mus musculus | RAR-related orphan receptor gamma | Starlite/ChEMBL | No references |
Homo sapiens | muscleblind-like splicing regulator 1 | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target/s | Ortholog Group |
---|---|---|---|
Echinococcus multilocularis | muscleblind protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Brugia malayi | Muscleblind-like protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Echinococcus multilocularis | muscleblind protein 1 | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Echinococcus granulosus | muscleblind protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Loa Loa (eye worm) | hypothetical protein | Get druggable targets OG5_132352 | All targets in OG5_132352 |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | hexokinase | 0.008 | 0.1608 | 0.2746 |
Trypanosoma cruzi | hexokinase, putative | 0.008 | 0.1608 | 0.5 |
Trypanosoma brucei | hexokinase | 0.008 | 0.1608 | 0.5 |
Echinococcus granulosus | hexokinase | 0.008 | 0.1608 | 0.2746 |
Echinococcus multilocularis | muscleblind protein 1 | 0.018 | 0.4556 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0055 | 0.0858 | 0.1884 |
Brugia malayi | ecdysteroid receptor | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Nuclear hormone receptor family member nhr-41 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Nuclear hormone receptor family member nhr-40 | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | hexokinase | 0.008 | 0.1608 | 0.3529 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-14 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | nuclear hormone receptor | 0.0042 | 0.0492 | 0.108 |
Echinococcus granulosus | hexokinase type 2 | 0.008 | 0.1608 | 0.2746 |
Trypanosoma brucei | hexokinase, putative | 0.008 | 0.1608 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Entamoeba histolytica | hexokinase 1 | 0.008 | 0.1608 | 0.5 |
Trypanosoma brucei | hexokinase | 0.008 | 0.1608 | 0.5 |
Mycobacterium tuberculosis | NADH-dependent enoyl-[acyl-carrier-protein] reductase InhA (NADH-dependent enoyl-ACP reductase) | 0.0365 | 1 | 0.5 |
Onchocerca volvulus | 0.008 | 0.1608 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Toxoplasma gondii | enoyl-acyl carrier reductase ENR | 0.0365 | 1 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Hexokinase family protein | 0.008 | 0.1608 | 0.3529 |
Mycobacterium leprae | NADH-DEPENDENT ENOYL-[ACYL-CARRIER-PROTEIN] REDUCTASE INHA (NADH-DEPENDENT ENOYL-ACP REDUCTASE) | 0.0365 | 1 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Plasmodium falciparum | enoyl-acyl carrier reductase | 0.0365 | 1 | 1 |
Trichomonas vaginalis | hypothetical protein | 0.0365 | 1 | 0.5 |
Loa Loa (eye worm) | hexokinase type II | 0.008 | 0.1608 | 0.3529 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0042 | 0.0492 | 0.108 |
Leishmania major | hexokinase, putative | 0.008 | 0.1608 | 0.5 |
Onchocerca volvulus | Hexokinase homolog | 0.005 | 0.073 | 0.2127 |
Brugia malayi | Nuclear hormone receptor family member nhr-31 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Muscleblind-like protein | 0.018 | 0.4556 | 1 |
Loa Loa (eye worm) | hexokinase | 0.008 | 0.1608 | 0.3529 |
Trypanosoma cruzi | hexokinase, putative | 0.008 | 0.1608 | 0.5 |
Loa Loa (eye worm) | hexokinase | 0.005 | 0.073 | 0.1601 |
Brugia malayi | Hexokinase family protein | 0.005 | 0.073 | 0.1601 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-40 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | nuclear receptor NHR-88 | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.4556 | 1 |
Treponema pallidum | hexokinase (hxk) | 0.008 | 0.1608 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Leishmania major | hexokinase, putative | 0.008 | 0.1608 | 0.5 |
Brugia malayi | Nuclear hormone receptor-like 1 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Nuclear hormone receptor family member nhr-3 | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-49 | 0.0042 | 0.0492 | 0.108 |
Onchocerca volvulus | 0.008 | 0.1608 | 1 | |
Wolbachia endosymbiont of Brugia malayi | enoyl-ACP reductase | 0.0365 | 1 | 0.5 |
Onchocerca volvulus | 0.008 | 0.1608 | 1 | |
Echinococcus granulosus | muscleblind protein | 0.018 | 0.4556 | 1 |
Echinococcus multilocularis | hexokinase | 0.008 | 0.1608 | 0.2746 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Steroid receptor seven-up type 2 | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | hexokinase | 0.008 | 0.1608 | 0.3529 |
Brugia malayi | Nuclear hormone receptor family member nhr-19 | 0.0042 | 0.0492 | 0.108 |
Entamoeba histolytica | hexokinase 2 | 0.008 | 0.1608 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-49 | 0.0042 | 0.0492 | 0.108 |
Echinococcus multilocularis | hexokinase type 2 | 0.008 | 0.1608 | 0.2746 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Mycobacterium ulcerans | enoyl-(acyl carrier protein) reductase | 0.0365 | 1 | 0.5 |
Brugia malayi | Nuclear hormone receptor family member nhr-14 | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | nuclear Hormone Receptor family member | 0.0042 | 0.0492 | 0.108 |
Plasmodium vivax | enoyl-acyl carrier protein reductase | 0.0365 | 1 | 1 |
Echinococcus granulosus | hexokinase | 0.008 | 0.1608 | 0.2746 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-41 | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | hypothetical protein | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | steroid hormone receptor | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Nuclear hormone receptor family member nhr-25 | 0.0042 | 0.0492 | 0.108 |
Onchocerca volvulus | 0.005 | 0.073 | 0.2127 | |
Schistosoma mansoni | hexokinase | 0.008 | 0.1608 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.018 | 0.4556 | 1 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-1 | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | Ligand-binding domain of nuclear hormone receptor family protein | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | nuclear hormone receptor family member nhr-31 | 0.0042 | 0.0492 | 0.108 |
Loa Loa (eye worm) | steroid hormone receptor | 0.0042 | 0.0492 | 0.108 |
Brugia malayi | photoreceptor-specific nuclear receptor | 0.0042 | 0.0492 | 0.108 |
Echinococcus multilocularis | hexokinase | 0.008 | 0.1608 | 0.2746 |
Echinococcus multilocularis | hexokinase | 0.008 | 0.1608 | 0.2746 |
Echinococcus multilocularis | muscleblind protein | 0.018 | 0.4556 | 1 |
Brugia malayi | Nuclear hormone receptor family member nhr-1 | 0.0042 | 0.0492 | 0.108 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | = 0.5012 um | PUBCHEM_BIOASSAY: VP16 counterscreen qHTS for inhibitors of ROR gamma transcriptional activity. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (binding) | 10 uM | PubChem BioAssay. qHTS Assay for Inhibitors of MBNL1-poly(CUG) RNA binding. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 11.6891 uM | PUBCHEM_BIOASSAY: Primary qHTS for delayed death inhibitors of the malarial parasite plastid, 96 hour incubation. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488745, AID488752, AID488774, AID504848, AID504850] | ChEMBL. | No reference |
Potency (functional) | 20.5962 uM | PubChem BioAssay. qHTS for induction of synthetic lethality in tumor cells producing 2HG: qHTS for the HT-1080-NT fibrosarcoma cell line. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 22.3872 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588856, AID588860] | ChEMBL. | No reference |
Potency (functional) | = 25.1189 um | PUBCHEM_BIOASSAY: qHTS Assay for Agonists of the Relaxin Receptor RXFP1. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS of GLP-1 Receptor Inverse Agonists (Inhibition Mode). (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 28.1838 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Potency (functional) | 29.0929 uM | PUBCHEM_BIOASSAY: Nrf2 qHTS screen for inhibitors. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID493153, AID493163, AID504648] | ChEMBL. | No reference |
Potency (functional) | 35.4813 uM | PUBCHEM_BIOASSAY: qHTS for Inhibitors of TGF-b: Cytotox Counterscreen. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID588855, AID588860] | ChEMBL. | No reference |
Potency (functional) | 70.7946 uM | PUBCHEM_BIOASSAY: qHTS assay for re-activators of p53 using a Luc reporter. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID504709] | ChEMBL. | No reference |
Potency (functional) | 89.1251 uM | PUBCHEM_BIOASSAY: Inhibitors of TCP-1 ring complex (TRiC) of Methanococcus maripaludis (MmCpn): qHTS. (Class of assay: confirmatory) [Related pubchem assays (depositor defined):AID488991] | ChEMBL. | No reference |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.